Egesta Lopci
Humanitas University
CancerInternal medicineRadiologyPET-CTPathologyOncologyPositron emission tomographyBiopsyLung cancerChemotherapyCarcinomaImmunotherapyContext (language use)Prostate cancerNuclear medicineIn patientFdg pet ctRadiation therapyMedicineGastroenterology
183Publications
26H-index
2,120Citations
Publications 184
Newest
#2Egesta LopciH-Index: 26
Last. Ken Herrmann (University of Duisburg-Essen)H-Index: 67
view all 6 authors...
Hematologic malignancies represent a vast group of hematopoietic and lymphoid cancers that typically involve the blood, the bone marrow, and the lymphatic organs. Due to extensive research and well defined and standardized response criteria, the role of [18F]FDG-PET/CT is well defined in these malignancies. Never the less, the reliability of visual and quantitative interpretation of PET/CT may be impaired by several factors including inconsistent scanning protocols and image reconstruction metho...
Source
#1Angelo CastelloH-Index: 10
#2Paola CaroliH-Index: 10
Last. Egesta LopciH-Index: 26
view all 3 authors...
Source
#1Matteo BaucknehtH-Index: 15
#2Carlo Genova (UniGe: University of Genoa)H-Index: 22
Last. Silvia Chiola (UniGe: University of Genoa)
view all 19 authors...
An emerging clinical need is represented by identifying reliable biomarkers able to discriminate between responders and non-responders among patients showing imaging progression during the administration of immune checkpoints inhibitors for advanced non-small cell lung cancer (NSCLC). In the present study, we analyzed the prognostic power of peripheral-blood systemic inflammation indexes and 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in this clinical set...
Source
Multiparametric magnetic resonance imaging (mpMRI) is the modality of choice for initial diagnosis of prostate cancer (PCa), including biopsy-naive patients. Nevertheless, clinicians must be aware of the possibility that up to one-fourth of clinically significant cancers might be missed by the modality. Acknowledgment of this occurrence and the increased availability of 68 Ga-PSMA PET/CT in clinical routine, open the door to new, fascinating, indications for this functional modality in the conte...
Source
#1Valli De ReH-Index: 28
#1Valli De ReH-Index: 1
Last. Roberta BurnelliH-Index: 13
view all 18 authors...
Several studies have examined the prognostic performance of therapeutic groups (TG) and early responses to therapy on positron emission tomography/computed tomography (PET/CT) in children and adolescents with classical Hodgkin lymphoma (cHL); less research has been performed on molecular parameters at diagnosis. The aim of the present study was to devise a scoring system based on the TG criteria for predicting freedom from progression (FFP) in 133 patients: 63.2% males; 14 years median age (inte...
Source
#1Egesta LopciH-Index: 26
#2Carsten Kobe (University of Cologne)H-Index: 30
Last. Lioe-Fee de Geus-Oei (LUMC: Leiden University Medical Center)H-Index: 30
view all 5 authors...
2-deoxy-2-[18F]fluoro-D-glucose [18F]FDG-PET/CT represents the metabolic imaging of choice in various cancer types. Used either at diagnosis or during treatment response assessment, the modality allows for a more accurate definition of tumor extent compared to morphological imaging and is able to predict the therapeutic benefit earlier in time. Due to the aspecific uptake property of [18F]FDG there is an overlap of its distribution in normal and pathological conditions, which can make the interp...
Source
Source
#1Egesta LopciH-Index: 26
#2Roberta BurnelliH-Index: 13
Last. Maurizio MascarinH-Index: 16
view all 9 authors...
Introduction Assessment of response to therapy in paediatric patients with Hodgkin lymphoma (HL) by 18F-fluorodeoxyglucose positron emission tomography/CT has become a powerful tool for the discrimination of responders from non-responders. The addition of volumetric and texture analyses can be regarded as a valuable help for disease prognostication and biological characterisation. Based on these premises, the Hodgkin Lymphoma Study Group of the Associazione Italiana Ematologia Oncologia Pediatri...
Source
#1Angelo CastelloH-Index: 10
#2Sabrina RossiH-Index: 18
Last. Egesta LopciH-Index: 26
view all 4 authors...
Introduction: In the current study, we aimed to assess the impact of antibiotics (ATB) and metabolic parameters on clinical outcome of non-small cell lung carcinoma (NSCLC) patients treated with immune checkpoint inhibitors (ICI). Methods: Data from fifty NSCLC patients referred for ICI between December 2015 and May 2019 were analyzed. All patients underwent 18F-fluorodeoxyglucose positron emission tomography computed tomography (18F-FDG PET/CT) and contrast-enhanced CT at baseline and for respo...
1 CitationsSource
#1Matteo DonadonH-Index: 22
#2Egesta LopciH-Index: 26
Last. Guido TorzilliH-Index: 55
view all 9 authors...
11C-choline positron emission tomography/computed tomography (PET/CT) has been used for patients with some types of tumors, but few data are available for hepatocellular carcinoma (HCC). We queried our prospective database for patients with HCC staged with 11C-choline PET/CT to assess the clinical impact of this imaging modality. Seven parameters were recorded: maximum standardized uptake value (SUVmax), mean standardized uptake value (SUVmean), liver standardized uptake value (SUVliver), metabo...
1 CitationsSource